Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
Activity Details
174
Mon, 7/30/2018,
10:30 AM -
12:20 PM
CC-West 210
Biomarkers and Endpoint Validation — Contributed Papers
Biopharmaceutical Section
Chair(s): Veronica Powell, QST Consultations
10:35 AM
Leveraging Omics Biomarker in Early Clinical Trials - Concept, Utility and Impact on Decision Making
Weidong Zhang, Pfizer Inc.
10:50 AM
Inference on Treatment Effect Modification by Marker Response in a Baseline Surrogate Measure Three-Phase Sampling Design
Michal Juraska, Fred Hutchinson Cancer Research Center ; Ying Huang, Fred Hutchinson Cancer Research Center; Peter Gilbert, Fred Hutchinson Cancer Research Center
11:05 AM
Comparison of Methods to Generate Reference Limits
Bipasa Biswas, CDRH, FDA ; Nairita Ghosal, University of Illinois at Chicago
11:20 AM
An Analysis of MIMIC Data for Potential Surrogate Markers for Vaccine Development
Robert Small, Sanofi Pasteur; Pauline Jurvilliers, Sanofi Pasteur
11:35 AM
Statistics Used in Assay Validation
Kenneth Liu
11:50 AM
Longitudinal Models for Kidney Function Decline
Jing Zhang, Moores UCSD Cancer Center ; Loki Natarajan, UCSD; Kumar Sharma, Division of Nephrology,University of Texas Health San Antonio; Tina Costacou, University of Pittsburgh; Janet Snell-Bergeon , University of Colorado Anschutz Medical Campus, School of Medicine; Rachel Miller, University of Pittsburgh; Trevor Orchard, University of Pittsburgh
12:05 PM
Floor Discussion